Primary study · included by 1 review

Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2.

Diener 2021 · Diener Hans-Christoph, Marmura Michael J, Tepper Stewart J, et al. · Headache · 2021

Included by

A meta-analysis of pain intensity changes after placebo interventions in facial pain.

Non-Cochrane · other · 2026 · cited as Diener 2021 · Results para 1 included-study citation list (ref 29); 116 refs cited for 115 stated studies; Supplemental Tables 1 and 2 not available

The review does not say which of its outcomes this study informs.

1 including review in total.